FDA Inspection 1062457 — Mindray DS USA, Inc.
The FDA completed an inspection of Mindray DS USA, Inc. on April 20, 2018 in Mahwah, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 20, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Mahwah, NJ (United States)